|
NTLA
|
Intellia Therapeutics, Inc.
|
1.94%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
1.92%
|
US
|
NASDAQ
|
|
PKI
|
PerkinElmer, Inc.
|
1.79%
|
US
|
NYSE
|
|
CDMO
|
Avid Bioservices, Inc.
|
1.74%
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
1.27%
|
US
|
NYSE
|
|
PTCT
|
PTC Therapeutics, Inc.
|
1.21%
|
US
|
NASDAQ
|
|
LH
|
Laboratory Corporation of America Holdings
|
1.18%
|
US
|
NYSE
|
|
TECH
|
Techne Corporation
|
1.15%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
1.12%
|
US
|
NYSE
|
|
EXAS
|
Exact Sciences Corporation
|
1.09%
|
US
|
NASDAQ
|
|
IQV
|
IQVIA Holdings, Inc.
|
1.07%
|
US
|
NYSE
|
|
ICLR
|
ICON plc
|
1.05%
|
US
|
NASDAQ
|
|
CDNS
|
Cadence Design Systems, Inc.
|
1.04%
|
US
|
NASDAQ
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
0.96%
|
US
|
NYSE
|
|
EVT
|
Evotec SE
|
0.84%
|
DE
|
XETRA
|
|
DVAX
|
Dynavax Technologies Corporation
|
0.79%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.77%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.72%
|
US
|
NASDAQ
|
|
SDGR
|
Schrodinger, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.67%
|
US
|
NASDAQ
|